公司資料
InMed 股價、新聞與催化劑
- 股票代碼:
- INM
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Canada and listed in the U
股票表現
1.46 USD (-0.68%)
收盤價
最後更新: 2026年8月17日
5.04M USD
市值
股價為何變動
As of Aug 17, 2026, INM closed down 0.68% at $1.46. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
InMed Pharmaceuticals is a biotechnology company focused on cannabinoids and related pharmaceutical applications. Its story is centered on whether cannabinoid science can be translated into differentiated medicines.
所在地與產業分類
InMed is headquartered in Canada and listed in the U.S. market. It sits in small-cap biotechnology with a cannabinoid focus.
商業模式特徵
The company depends on clinical and preclinical validation, regulatory clarity, and capital efficiency. Investors usually watch early data, platform direction, and whether the company can sharpen its therapeutic thesis.
生技產業定位
InMed occupies a niche cannabinoid biotech position. The stock is catalyst-sensitive because the company must prove both scientific and commercial relevance.
未來催化劑
- InMed’s catalysts are pharmaceutical-cannabinoid programs and any update that clarifies whether the company can still turn the platform into a viable development path. The market will care about human proof.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。